Epithelial-mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine-rich alpha-2 glycoprotein.
Cadherins
/ metabolism
Carcinoma, Pancreatic Ductal
/ metabolism
Cell Line
Cell Line, Tumor
Disease-Free Survival
Epithelial-Mesenchymal Transition
/ physiology
Female
Glycoproteins
/ metabolism
Hep G2 Cells
Human Umbilical Vein Endothelial Cells
Humans
Inflammation
/ metabolism
Leucine
/ metabolism
Male
Neoplasm Recurrence, Local
/ metabolism
Pancreatic Neoplasms
/ metabolism
Phosphorylation
/ physiology
Signal Transduction
/ physiology
Smad2 Protein
/ metabolism
Transforming Growth Factor beta1
/ metabolism
epithelial-mesenchymal transition
inflammation
leucine-rich a2-glycoprotein
metastasis
pancreatic cancer
Journal
Cancer science
ISSN: 1349-7006
Titre abrégé: Cancer Sci
Pays: England
ID NLM: 101168776
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
28
02
2018
revised:
17
12
2018
accepted:
18
12
2018
pubmed:
24
12
2018
medline:
9
3
2019
entrez:
22
12
2018
Statut:
ppublish
Résumé
We previously showed that an inflammation-related, molecule leucine-rich alpha-2 glycoprotein (LRG) enhances the transforming growth factor (TGF)-β1-induced phosphorylation of Smad proteins and is elevated in patients with pancreatic ductal adenocarcinoma (PDAC). As TGF-β/Smad signaling is considered to play a key role in epithelial-mesenchymal transition (EMT), we attempted to clarify the mechanism underlying LRG-related EMT in relation to metastasis in PDAC. We cultured LRG-overexpressing PDAC cells (Panc1/LRG) and evaluated the morphology, EMT-related molecules and TGF-β/Smad signaling pathway in these cells. We also assessed the LRG levels in plasma and resected specimens from patients with PDAC. Inflammatory cytokines induced LRG production in PDAC cells. A spindle-like shape was visualized more frequently than other shapes in Panc1/LRG with TGF-β1 exposure. The expression of E-cadherin in Panc1/LRG was decreased with TGF-β1 exposure. Invasion increased with TGF-β1 stimulation of Panc1/LRG. The phosphorylation of smad2 in Panc1/LRG was increased in comparison with parental Panc1 under TGF-β1 stimulation. In the plasma LRG-high group, the recurrence rate tended to be higher and the recurrence-free survival (RFS) tended to be worse in comparison with the plasma LRG-low group. LRG enhanced EMT induced by TGF-β signaling, thus indicating that LRG has a significant effect on the metastasis of PDAC.
Identifiants
pubmed: 30575211
doi: 10.1111/cas.13918
pmc: PMC6398893
doi:
Substances chimiques
Cadherins
0
Glycoproteins
0
Smad2 Protein
0
TGFB1 protein, human
0
Transforming Growth Factor beta1
0
Leucine
GMW67QNF9C
Banques de données
GENBANK
['ab178698']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
985-996Subventions
Organisme : Japan Agency for Medical Research and Development
ID : 15ek0109045h0002
Organisme : JSPS KAKENHI Grant-in-Aid for Young Scientists (Start-up)
ID : 15H06918
Organisme : Grant-in-Aid for Scientific Research
ID : 17H04215
Organisme : Grant-in-Aid for Scientific Research
ID : 15K10202
Organisme : Bristol-Myers Squibb Foundation
Informations de copyright
© 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Références
Eur J Cancer. 2013 May;49(7):1725-40
pubmed: 23298711
Inflamm Bowel Dis. 2012 Nov;18(11):2169-79
pubmed: 22374925
Hepatogastroenterology. 2013 Jun;60(124):904-11
pubmed: 23321032
Int J Cancer. 1998 Jan 19;75(2):284-9
pubmed: 9462720
Int J Cancer. 2015 Sep 1;137(5):1035-46
pubmed: 25604508
Cancer Sci. 2017 Oct;108(10):2052-2060
pubmed: 28746773
J Clin Invest. 2006 Jul;116(7):1843-52
pubmed: 16767220
EMBO J. 2002 Dec 2;21(23):6473-82
pubmed: 12456654
JAMA. 2013 Oct 9;310(14):1473-81
pubmed: 24104372
Neoplasma. 2011;58(5):396-405
pubmed: 21744993
Ann Surg Oncol. 2017 Nov;24(12):3715-3724
pubmed: 28849575
Oncotarget. 2017 Feb 7;8(6):9961-9973
pubmed: 28035069
Ann Gastroenterol Surg. 2017 Apr 25;1(1):5-10
pubmed: 29863129
Arthritis Rheumatol. 2015 May;67(8):2056-60
pubmed: 25917892
Nat Rev Cancer. 2010 Jun;10(6):415-24
pubmed: 20495575
Hepatology. 2005 Dec;42(6):1329-38
pubmed: 16317687
Dig Surg. 2018;35(1):70-76
pubmed: 28482348
Nature. 2013 Jul 18;499(7458):306-11
pubmed: 23868260
Clin Cancer Res. 2000 Jul;6(7):2881-90
pubmed: 10914738
Cardiovasc Res. 2016 Feb 1;109(2):272-82
pubmed: 26678356
Cancer Sci. 2019 Mar;110(3):985-996
pubmed: 30575211
Jpn J Clin Oncol. 2014 Dec;44(12):1172-80
pubmed: 25425728
Br J Cancer. 2011 Oct 25;105(9):1370-8
pubmed: 21970875
Oncotarget. 2015 Feb 20;6(5):3085-97
pubmed: 25609203
Cancer Res. 2001 May 15;61(10):4222-8
pubmed: 11358848
Jpn J Clin Oncol. 1998 Jan;28(1):12-5
pubmed: 9491135
Medicine (Baltimore). 2017 Feb;96(5):e5926
pubmed: 28151872
J Leukoc Biol. 2008 May;83(5):1277-85
pubmed: 18272588
Pancreas. 2015 Jul;44(5):756-63
pubmed: 25931255
PLoS One. 2016 Sep 09;11(9):e0162672
pubmed: 27611322
Oncotarget. 2015 May 10;6(13):11009-22
pubmed: 25826092
Int J Clin Lab Res. 1995;25(1):40-3
pubmed: 7787209
Proc Natl Acad Sci U S A. 1985 Apr;82(7):1906-10
pubmed: 3856868
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Gastroenterology. 2005 Jun;128(7):2054-65
pubmed: 15940637
J Clin Biochem Nutr. 2014 Jul;55(1):56-61
pubmed: 25120280
Pancreas. 2015 Jan;44(1):93-8
pubmed: 25058884
Int J Cancer. 2016 Mar 1;138(5):1118-28
pubmed: 26413860
Lancet. 2016 Jul 16;388(10041):248-57
pubmed: 27265347
Tumour Biol. 2015 Mar;36(3):1375-84
pubmed: 25680410
J Korean Med Sci. 2014 Sep;29(9):1199-204
pubmed: 25246736
Cancer Chemother Pharmacol. 2014 Feb;73(2):309-15
pubmed: 24258457
Ann Rheum Dis. 2010 Apr;69(4):770-4
pubmed: 19854709
Hepatogastroenterology. 1999 Jan-Feb;46(25):8-15
pubmed: 10228758
Arthritis Res Ther. 2017 Jun 14;19(1):137
pubmed: 28615031
Cell Tissue Res. 2016 Sep;365(3):495-506
pubmed: 27461257
Blut. 1977 Sep 29;35(3):229-39
pubmed: 71929
Hepatobiliary Pancreat Dis Int. 2014 Aug;13(4):371-80
pubmed: 25100121
Biochem Biophys Res Commun. 2009 May 15;382(4):776-9
pubmed: 19324010
Cancer Res. 2015 Jun 1;75(11):2292-304
pubmed: 25840985
J Leukoc Biol. 2002 Sep;72(3):478-85
pubmed: 12223515